Breaking News Instant updates and real-time market news.

ACAD

Acadia

$14.03

-0.16 (-1.13%)

09:32
08/09/18
08/09
09:32
08/09/18
09:32

Acadia price target lowered to $27 from $50 at JMP Securities

JMP Securities analyst Jason Butler lowered his price target on Acadia to $27 from $50 to reflect what he called a "speed bump" for Nuplazid, but he said he still has confidence in the product's profile and commercial potential. Nuplazid growth has been hurt by the negative and, in his view, overstated safety concerns reported in the media, said Butler, who added that he believes trends discussed by management "support a timely return to growth." Butler keeps an Outperform rating on Acadia.

  • 30

    Aug

  • 31

    Aug

ACAD Acadia
$14.03

-0.16 (-1.13%)

08/09/18
HCWC
08/09/18
NO CHANGE
Target $60
HCWC
Buy
Acadia guidance creates attractive entry point, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein believes Acadia Pharmaceuticals' lowered guidance for 2018 creates an attractive entry point for the shares. The outlook clears the overhang on the company, which should allow for a more "pure" entry point for new investors seeking to capitalize on Acadia's "depressed share price," Fein tells investors in a research note. He reiterates a Buy rating on Acadia with a $60 price target.
08/07/18
STFL
08/07/18
INITIATION
Target $17
STFL
Hold
Acadia initiated with a Hold at Stifel
Stifel analyst Paul Matteis initiated coverage of Acadia with a Hold rating and a $17 price target, stating that he believes a company update on the ongoing pimavanserin FDA safety review in the second of this year or early 2019 will remove an overhang. However, his estimates are "materially below consensus" in 2019 and he expect pimavanserin to "churn its way" to $594M in PDP revenue by 2022, which is also materially below sell-side expectations.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.
08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

F

Ford

$9.41

-0.17 (-1.77%)

06:27
04/26/19
04/26
06:27
04/26/19
06:27
Conference/Events
Ford management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

KHC

Kraft Heinz

$32.51

-0.26 (-0.79%)

06:25
04/26/19
04/26
06:25
04/26/19
06:25
Periodicals
Kraft Heinz struggling to sell Maxwell House, NY Post reports »

Kraft Heinz has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

, SBGI

Sinclair Broadcast

$44.26

-0.46 (-1.03%)

06:24
04/26/19
04/26
06:24
04/26/19
06:24
Periodicals
Amazon may join Sinclair to bid on regional sports networks, NY Post says »

Amazon (AMZN) is in talks…

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

SBGI

Sinclair Broadcast

$44.26

-0.46 (-1.03%)

DIS

Disney

$137.30

2.2 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 08

    May

  • 08

    May

  • 10

    May

  • 22

    May

  • 03

    Jun

TXRH

Texas Roadhouse

$60.73

0.54 (0.90%)

06:23
04/26/19
04/26
06:23
04/26/19
06:23
Initiation
Texas Roadhouse initiated at UBS »

Texas Roadhouse initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 23

    May

  • 13

    Nov

AXU

Alexco Resource

$1.00

0.0374 (3.89%)

06:23
04/26/19
04/26
06:23
04/26/19
06:23
Conference/Events
Alexco Resource management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

  • 09

    May

VFC

VF Corp.

$94.00

-0.72 (-0.76%)

06:23
04/26/19
04/26
06:23
04/26/19
06:23
Hot Stocks
VF Corp. says separation into Kontoor Brands on track for late May »

The separation of VF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAT

Brinker

$43.74

0.11 (0.25%)

06:23
04/26/19
04/26
06:23
04/26/19
06:23
Initiation
Brinker initiated  »

Brinker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 20

    May

  • 13

    Nov

BRK.A

Berkshire Hathaway

$318,260.00

2285 (0.72%)

, BRK.B

Berkshire Hathaway

$212.07

1.54 (0.73%)

06:22
04/26/19
04/26
06:22
04/26/19
06:22
Periodicals
Buffett says Berkshire Hathaway could buy back up to $100B, FT reports »

Warren Buffett says…

BRK.A

Berkshire Hathaway

$318,260.00

2285 (0.72%)

BRK.B

Berkshire Hathaway

$212.07

1.54 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 04

    May

DRI

Darden

$119.14

1.22 (1.03%)

06:22
04/26/19
04/26
06:22
04/26/19
06:22
Initiation
Darden initiated  »

Darden initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$49.28

0.29 (0.59%)

06:22
04/26/19
04/26
06:22
04/26/19
06:22
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 10

    Jun

PKG

Packaging Corp.

$97.96

-0.9 (-0.91%)

06:21
04/26/19
04/26
06:21
04/26/19
06:21
Downgrade
Packaging Corp. rating change at Stephens »

Packaging Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 13

    Nov

VFC

VF Corp.

$94.00

-0.72 (-0.76%)

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Hot Stocks
VF Corp. provides initial 2020-2021 outlook for Kontoor Brands »

Kontoor Brands'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NESR

National Energy Services

$10.65

-0.07 (-0.65%)

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Conference/Events
National Energy Services management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

UBS

UBS

06:20
04/26/19
04/26
06:20
04/26/19
06:20
Downgrade
UBS rating change  »

UBS downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 03

    Jun

ESPR

Esperion

$43.02

1.14 (2.72%)

06:19
04/26/19
04/26
06:19
04/26/19
06:19
Upgrade
Esperion rating change at Goldman Sachs »

Goldman upgrades Esperion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

VFC

VF Corp.

$94.00

-0.72 (-0.76%)

06:19
04/26/19
04/26
06:19
04/26/19
06:19
Earnings
VF Corp. sees Kontoor Brands FY19 revenue exceeding $2.5B »

The initial outlook for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.47

0.13 (0.85%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Hot Stocks
Petrobras executes three agreements for sale of assets totaling $10.3B »

Petrobras said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$193.23

10.59 (5.80%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Periodicals
FTC officials mull constraints for Facebook's business practices, NY Times says »

Members of the Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

WDC

Western Digital

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Downgrade
Western Digital rating change at Baird »

Western Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

IRM

Iron Mountain

$32.67

-3.17 (-8.84%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Downgrade
Iron Mountain rating change  »

Iron Mountain downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

GLNCY

Glencore

$0.00

(0.00%)

06:17
04/26/19
04/26
06:17
04/26/19
06:17
Conference/Events
Glencore management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

CAE

CAE

$23.23

0.205 (0.89%)

06:16
04/26/19
04/26
06:16
04/26/19
06:16
Downgrade
CAE rating change at National Bank »

CAE downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$40.22

-0.32 (-0.79%)

06:16
04/26/19
04/26
06:16
04/26/19
06:16
Downgrade
Audentes Therapeutics rating change  »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

MDCO

The Medicines Co.

$29.84

0.37 (1.26%)

06:15
04/26/19
04/26
06:15
04/26/19
06:15
Upgrade
The Medicines Co. rating change at Goldman Sachs »

Goldman Sachs sees 90%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 08

    May

RACE

Ferrari

$135.57

-0.91 (-0.67%)

06:15
04/26/19
04/26
06:15
04/26/19
06:15
Downgrade
Ferrari rating change  »

Ferrari downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.